These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 32795556)

  • 1. NLRP3 Inflammasomes in Parkinson's disease and their Regulation by Parkin.
    Yan YQ; Fang Y; Zheng R; Pu JL; Zhang BR
    Neuroscience; 2020 Oct; 446():323-334. PubMed ID: 32795556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuronal NLRP3 is a parkin substrate that drives neurodegeneration in Parkinson's disease.
    Panicker N; Kam TI; Wang H; Neifert S; Chou SC; Kumar M; Brahmachari S; Jhaldiyal A; Hinkle JT; Akkentli F; Mao X; Xu E; Karuppagounder SS; Hsu ET; Kang SU; Pletnikova O; Troncoso J; Dawson VL; Dawson TM
    Neuron; 2022 Aug; 110(15):2422-2437.e9. PubMed ID: 35654037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small molecule-driven NLRP3 inflammation inhibition via interplay between ubiquitination and autophagy: implications for Parkinson disease.
    Han X; Sun S; Sun Y; Song Q; Zhu J; Song N; Chen M; Sun T; Xia M; Ding J; Lu M; Yao H; Hu G
    Autophagy; 2019 Nov; 15(11):1860-1881. PubMed ID: 30966861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammasome inhibition prevents α-synuclein pathology and dopaminergic neurodegeneration in mice.
    Gordon R; Albornoz EA; Christie DC; Langley MR; Kumar V; Mantovani S; Robertson AAB; Butler MS; Rowe DB; O'Neill LA; Kanthasamy AG; Schroder K; Cooper MA; Woodruff TM
    Sci Transl Med; 2018 Oct; 10(465):. PubMed ID: 30381407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of NLRP3 inflammasome ameliorates LPS-induced neuroinflammatory injury in mice via PINK1/Parkin pathway.
    Wang A; Zhong G; Ying M; Fang Z; Chen Y; Wang H; Wang C; Liu C; Guo Y
    Neuropharmacology; 2024 Oct; 257():110063. PubMed ID: 38972372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of NLRP3 Inflammasome, Pyroptosis, and Cell Death by NIM811 in Rotenone-Exposed Cells as an in vitro Model of Parkinson's Disease.
    Zhang M; He Q; Chen G; Li PA
    Neurodegener Dis; 2020; 20(2-3):73-83. PubMed ID: 33176317
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NF-κB/NLRP3 inflammasome axis and risk of Parkinson's disease in Type 2 diabetes mellitus: A narrative review and new perspective.
    Alrouji M; Al-Kuraishy HM; Al-Gareeb AI; Alexiou A; Papadakis M; Jabir MS; Saad HM; Batiha GE
    J Cell Mol Med; 2023 Jul; 27(13):1775-1789. PubMed ID: 37210624
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic activation of NLRP3 inflammasome and plasma α-synuclein levels are correlated with motor severity and progression in Parkinson's disease.
    Fan Z; Pan YT; Zhang ZY; Yang H; Yu SY; Zheng Y; Ma JH; Wang XM
    J Neuroinflammation; 2020 Jan; 17(1):11. PubMed ID: 31915018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Andrographolide suppresses NLRP3 inflammasome activation in microglia through induction of parkin-mediated mitophagy in in-vitro and in-vivo models of Parkinson disease.
    Ahmed S; Kwatra M; Ranjan Panda S; Murty USN; Naidu VGM
    Brain Behav Immun; 2021 Jan; 91():142-158. PubMed ID: 32971182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkin deficiency modulates NLRP3 inflammasome activation by attenuating an A20-dependent negative feedback loop.
    Mouton-Liger F; Rosazza T; Sepulveda-Diaz J; Ieang A; Hassoun SM; Claire E; Mangone G; Brice A; Michel PP; Corvol JC; Corti O
    Glia; 2018 Aug; 66(8):1736-1751. PubMed ID: 29665074
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine Secretion and Pyroptosis of Thyroid Follicular Cells Mediated by Enhanced NLRP3, NLRP1, NLRC4, and AIM2 Inflammasomes Are Associated With Autoimmune Thyroiditis.
    Guo Q; Wu Y; Hou Y; Liu Y; Liu T; Zhang H; Fan C; Guan H; Li Y; Shan Z; Teng W
    Front Immunol; 2018; 9():1197. PubMed ID: 29915579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Parkin regulates microglial NLRP3 and represses neurodegeneration in Parkinson's disease.
    Yan YQ; Zheng R; Liu Y; Ruan Y; Lin ZH; Xue NJ; Chen Y; Zhang BR; Pu JL
    Aging Cell; 2023 Jun; 22(6):e13834. PubMed ID: 37029500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-7 targets Nod-like receptor protein 3 inflammasome to modulate neuroinflammation in the pathogenesis of Parkinson's disease.
    Zhou Y; Lu M; Du RH; Qiao C; Jiang CY; Zhang KZ; Ding JH; Hu G
    Mol Neurodegener; 2016 Apr; 11():28. PubMed ID: 27084336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. α-Synuclein evokes NLRP3 inflammasome-mediated IL-1β secretion from primary human microglia.
    Pike AF; Varanita T; Herrebout MAC; Plug BC; Kole J; Musters RJP; Teunissen CE; Hoozemans JJM; Bubacco L; Veerhuis R
    Glia; 2021 Jun; 69(6):1413-1428. PubMed ID: 33506583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The zebrafish NLRP3 inflammasome has functional roles in ASC-dependent interleukin-1β maturation and gasdermin E-mediated pyroptosis.
    Li JY; Wang YY; Shao T; Fan DD; Lin AF; Xiang LX; Shao JZ
    J Biol Chem; 2020 Jan; 295(4):1120-1141. PubMed ID: 31852739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease.
    Wang S; Yuan YH; Chen NH; Wang HB
    Int Immunopharmacol; 2019 Feb; 67():458-464. PubMed ID: 30594776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From inflammasome to Parkinson's disease: Does the NLRP3 inflammasome facilitate exosome secretion and exosomal alpha-synuclein transmission in Parkinson's disease?
    Si XL; Fang YJ; Li LF; Gu LY; Yin XZ; Jun-Tian ; Yan YP; Pu JL; Zhang BR
    Exp Neurol; 2021 Feb; 336():113525. PubMed ID: 33161049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Taking the parkin brakes off of neuronal NLRP3 drives inflammasome activation and neurodegeneration in Parkinson's disease.
    Zengeler KE; Lukens JR
    Neuron; 2022 Aug; 110(15):2356-2358. PubMed ID: 35926449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of NLRP3 Inflammasome in Parkinson's Disease and Therapeutic Considerations.
    Nguyen LTN; Nguyen HD; Kim YJ; Nguyen TT; Lai TT; Lee YK; Ma HI; Kim YE
    J Parkinsons Dis; 2022; 12(7):2117-2133. PubMed ID: 35988226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Perillyl Alcohol Attenuates NLRP3 Inflammasome Activation and Rescues Dopaminergic Neurons in Experimental In Vitro and In Vivo Models of Parkinson's Disease.
    Ahmed S; Panda SR; Kwatra M; Sahu BD; Naidu V
    ACS Chem Neurosci; 2022 Jan; 13(1):53-68. PubMed ID: 34904823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.